UC San Diego Health Scales AI Enterprise-Wide

Introduction: A Vision for Enterprise AI

Scaling artificial intelligence in healthcare demands strong institutional infrastructure, clear strategy, and disciplined execution. Enthusiasm alone is never enough. UC San Diego Health is proving that point — and Dr. Alexander Khalessi is leading the charge.

As the newly appointed Chief Innovation Officer, Dr. Khalessi oversees AI integration and digital transformation across a seven-campus health system. He combines academic rigor with clinical urgency. As a result, his approach creates a model that other health systems are watching closely.

Who Is Dr. Alexander Khalessi?

A Surgeon Turned Innovation Leader

Dr. Khalessi has served at UC San Diego since 2011. He continues to chair the Department of Neurological Surgery. Furthermore, he is an internationally recognized cranial and endovascular neurosurgeon who holds degrees from Stanford, Johns Hopkins, and MIT’s Sloan School of Management.

In December 2024, he stepped into his enterprise innovation role. He also serves as Interim Assistant Vice Chancellor for Health Sciences Innovation and AI. Together, these roles place him at the center of UC San Diego’s digital transformation strategy.

“When you have the ambition to build something without precedent, it’s critical to lean into the combined capabilities, expertise, and infrastructure that makes your institution special,” said Dr. Khalessi.

Building an AI-Ready Health System

Strategy Before Speed

UC San Diego Health does not rush AI adoption. Instead, the system follows a deliberate, structured approach. This ensures safety, transparency, and measurable outcomes at every step. Dr. Khalessi emphasizes leveraging what already makes the institution exceptional — its research enterprise, clinical expertise, and academic depth.

Moreover, his dual role as clinician and innovation leader gives him direct insight into what works at the bedside. This perspective shapes every technology decision the system makes.

Three Phases of AI Technology Adoption

How UC San Diego Evaluates and Deploys AI

UC San Diego Health uses a consistent three-phase framework when adopting new AI technologies.

Phase 1 — Structured Pilots: The team first frames the problem clearly. They define success metrics upfront. Consequently, transparent outcomes drive every pilot forward.

Phase 2 — Validation and Scaling: After a successful pilot, the team validates findings across departments. They then build pathways to scale the technology responsibly.

Phase 3 — Enterprise Integration: Finally, approved tools integrate into clinical workflows, operational systems, and patient-facing platforms. Throughout this phase, governance and ethics frameworks remain active.

This phased approach reduces risk. It also builds trust among clinicians, administrators, and patients alike.

Five Care Environments Shaping the Future

A Comprehensive View of Tomorrow’s Healthcare

Dr. Khalessi envisions AI playing a transformative role across five distinct care environments.

1. Health Span and Prevention The first domain focuses on keeping people healthy longer. Wearables, nutrition science, sleep technology, and exercise data all contribute to this goal. AI synthesizes these inputs into actionable health guidance.

2. Early Disease Detection Personalized baseline data from genetics and wearables enables earlier disease detection. Timely intervention becomes possible when patterns emerge before symptoms appear.

3. Complex Acute Care At the heart of healthcare delivery sits serious, complex illness. Clinicians receive AI-powered support through decision tools, imaging analysis, and real-time patient monitoring during critical episodes.

4. Post-Acute Recovery After discharge, functional outcomes need close attention. AI tools flag complications early, refine patient selection for therapies, and guide recovery protocols for better long-term results.

5. Chronic Disease Management Long-term care for chronic conditions demands consistency and personalization. Through automated monitoring and intelligent outreach, AI reduces the management burden on both patients and care teams.

AI in Clinical Practice: Real-World Applications

From Research to Results

UC San Diego Health already deploys AI across several meaningful clinical use cases. Academic experts at the institution have published extensively on early sepsis detection. Their models identify risk signals earlier, so clinical teams can intervene before complications escalate.

Additionally, the health system uses AI-powered decision models to evaluate imaging patterns in certain cancers. These models also assess solitary pulmonary nodules on chest X-rays. As a result, radiologists receive a second layer of intelligent analysis. Each application reflects the system’s commitment to evidence-based AI — grounded in peer-reviewed research and tested in real clinical environments.

Operational AI: Removing Friction for Patients

Streamlining Access and Revenue Cycle

Beyond the clinic, UC San Diego Health uses AI to eliminate administrative friction. On the patient-facing side, the system has partnered with third-party vendors to build AI-enabled agents. These agents guide patients through preparation for elective procedures like colonoscopies. Consequently, patients arrive ready — and avoidable delays decrease significantly.

On the operational side, AI improves revenue cycle performance. It also helps patients access providers without delays caused by preauthorization processes. Smoother access means better outcomes and higher patient satisfaction.

The Academic Advantage in AI Innovation

Where Research Meets Clinical Practice

One of UC San Diego Health’s most powerful assets is its dual identity — a world-class research university and a destination care delivery system. This combination accelerates innovation in ways that standalone health systems cannot easily replicate.

Dr. Khalessi leverages this ecosystem deliberately. He connects faculty researchers with clinical operators. He also links academic discovery to commercialization pathways, engaging biotech partners across San Diego’s thriving life sciences corridor.

The Joan & Irwin Jacobs Center for Health Innovation serves as a central hub for this work. Its AI platform supports the training, deployment, and integration of AI models across the health system — all grounded in ethical, responsible principles.

CEO Patty Maysent captured the opportunity clearly: “Dr. Khalessi’s unique combination of clinical excellence, research expertise, and proven track record in building innovative programs positions him perfectly to lead our enterprise innovation strategy.”

Key Takeaways

UC San Diego Health’s enterprise AI strategy stands out because it combines institutional depth with clinical practicality. Dr. Khalessi brings a rare blend of surgical expertise, academic credibility, and business strategy to an industry that needs all three. Therefore, as AI continues reshaping healthcare, UC San Diego Health is building a national model — one structured pilot, one care environment, and one patient outcome at a time.